NEW YORK (360Dx) – Sepsis, which kills more than 250,000 people in America alone each year, is receiving growing attention from in vitro diagnostic industry players. In 2017, the US Food and Drug Administration cleared several new diagnostic tests, startups advanced technologies towards commercialization, and large industry players struck deals to strengthen their infectious disease testing menus.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.